)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Lepu Medical Technology Co
Lepu Medical Technology Co (300003) investor relations material
Lepu Medical Technology Co Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
9M 2026 revenue was RMB4.627bn, down 6.32% YoY; attributable net income was RMB678.29m, down 30.93%.
Results reflected lower drug and medical-device revenue, higher R&D spending and a one-time convertible-bond redemption premium; excluding the premium, adjusted attributable profit fell 22.01% YoY.
Financial highlights
Q3 revenue was RMB1.413bn, down 9.99% YoY; attributable net income was RMB178.81m, down 38.58%, and adjusted attributable profit was RMB169.57m, down 39.16%.
9M net income was RMB601.63m; attributable net income was RMB678.29m and adjusted attributable profit RMB650.33m, down 30.93% and 30.88%, respectively.
9M operating cash flow was RMB854.10m, down 15.66% YoY; R&D expense rose to RMB717.77m from RMB594.21m.
Outlook and guidance
Formulation revenue faced short-term channel-price disruption from national drug procurement renewal adjustments; the impact was expected to continue through year-end.
The polylactic-acid facial filler channel destocking was largely complete, with repeat purchases and sell-through aligned; the newly launched Sai Le Ti RF skin-treatment device was commercializing smoothly.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lepu Medical Technology Co
- Revenue and profit fell, but innovation and global expansion remain key growth strategies.300003
Q2 2026 - 2025 saw record profit growth and strong innovation momentum amid industry transformation.300003Q4 2025
- Revenue and net profit declined, but adjusted profit was resilient amid procurement pressures.300003Q1 2026
- Q3 net profit surged 176.18% year-over-year, driven by strong revenue and cash flow growth.300003Q3 2025
- Revenue and net profit were stable, with strong cash flow and continued innovation leadership.300003Q2 2025
- Q3 saw steep profit and revenue declines, offset by growth in core medical device segments.300003Q3 2024
- Revenue and profit fell, but cardiovascular and overseas segments grew; innovation pipeline advanced.300003Q2 2024
- Revenue and profit declined sharply, but innovation and global expansion drive future growth.300003Q4 2024
- Revenue declined year-over-year but sequential growth and strong cash flow marked Q1 2025.300003Q1 2025
Next Lepu Medical Technology Co earnings date
Q4 202623 Apr, 2027
Lepu Medical Technology Co
Next Lepu Medical Technology Co earnings date
Q4 202623 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)